Ascendis Pharma A/S is a biopharmaceutical company applying its proprietary TransCon technology platform to develop and commercialize therapies in endocrinology rare disease and oncology. Its approved products include SKYTROFA (lonapegsomatropin) for growth hormone deficiency in pediatric and adult patients, and YORVIPATH (palopegteriparatide) for hypoparathyroidism in adults. The company operates in the U.S. and EU and has additional pipeline candidates including TransCon CNP and oncology candidates.
429 total filings indexed. 429 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001612042 |
| Ticker | ASND |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | G7 |
| Website | https://www.ascendispharma.com |
| Listed | 2026-04-20 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ASND (~200 tokens, structured JSON with cryptographic provenance)